A preliminary study on bicalutamide for the treatment of prostatic hyperplasia

A preliminary study on bicalutamide for the treatment of prostatic hyperplasia

Bibliographic Details
Main Authors:	Liang Dai, Wang-teng Ma, Zi-xuan Song, Yi-min Wang
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Series:	Asian Journal of Surgery
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958423016986

Similar Items

Synthesis and Biological Evaluation of Bicalutamide Analogues for the Potential Treatment of Prostate Cancer
by: Sahar B. Kandil, et al.
Published: (2020-12-01)

Identification of bicalutamide resistance-related genes and prognosis prediction in patients with prostate cancer
by: Yuezheng Li, et al.
Published: (2023-04-01)

The ERα-NRF2 signalling axis promotes bicalutamide resistance in prostate cancer
by: Lei Tian, et al.
Published: (2022-11-01)

Compression-Induced Phase Transitions of Bicalutamide
by: Joanna Szafraniec-Szczęsny, et al.
Published: (2020-05-01)

Therapeutic benefits of maximum androgen blockade and tolerability of bicalutamide in patients with advanced prostate cancer
by: A E Aghaji, et al.
Published: (2004-01-01)

Impact of bicalutamide, an anti-androgen on rat testis
by: Azheen Subhi Abdulrahman, et al.
Published: (2019-04-01)

Apalutamide versus bicalutamide in combination with androgen deprivation therapy for metastatic hormone sensitive prostate cancer
by: Takashi Ueda, et al.
Published: (2024-01-01)

Successful recovery from multiple organ failure associated with bicalutamide and leuprorelin acetate for prostate cancer
by: Seiichi Saito
Published: (2020-03-01)

Complete Response to Bicalutamide Withdrawal Prolonged for Almost 2 Years in Patients With Metastatic Prostate Cancer
by: Hiroshi Hongo, et al.
Published: (2014-09-01)

Computational Analysis of Interactions between Androgen Receptor and Bicalutamide
by: Noushin Hadian, et al.
Published: (2017-03-01)

Cost-effectiveness of rezvilutamide versus bicalutamide and androgen-deprivation therapy in patients with highvolume, metastatic, hormone-sensitive prostate cancer
by: Huina Wu, et al.
Published: (2024-01-01)

Physicochemical Profile of Antiandrogen Drug Bicalutamide: Solubility, Distribution, Permeability
by: Tatyana V. Volkova, et al.
Published: (2022-03-01)

Radiological Findings of Prostatic Arterial Anatomy for Prostatic Arterial Embolization: Preliminary Study in 55 Chinese Patients with Benign Prostatic Hyperplasia.
by: Guodong Zhang, et al.
Published: (2015-01-01)

The Use of High-Intensity Focused Ultrasound (HIFU) Plus 150mg Bicalutamide as First Line Salvage Therapy for Local Recurrent Prostate Cancer
by: Jian-zhou Cao, et al.
Published: (2021-11-01)

Optimization, characterization, and follicular targeting assessment of tretinoin and bicalutamide loaded niosomes
by: Parisa Ghasemiyeh, et al.
Published: (2023-11-01)

Bicalutamide Anticancer Activity Enhancement by Formulation of Soluble Inclusion Complexes with Cyclodextrins
by: Federica De Gaetano, et al.
Published: (2022-11-01)

Molecular Disorder of Bicalutamide—Amorphous Solid Dispersions Obtained by Solvent Methods
by: Joanna Szafraniec, et al.
Published: (2018-10-01)

Chemical Degradation of Androgen Receptor (AR) Using Bicalutamide Analog–Thalidomide PROTACs
by: Ga Yeong Kim, et al.
Published: (2021-04-01)

ADME studies and preliminary safety pharmacology of LDT5, a lead compound for the treatment of benign prostatic hyperplasia
by: F. Noël, et al.

Drug treatment for benign prostatic hyperplasia.
by: Farmer, A, et al.
Published: (1997)

Drug treatment for benign prostatic hyperplasia
by: Farmer, A, et al.
Published: (1997)

Silodosin in the treatment of benign prostatic hyperplasia
by: Maxime Rossi, et al.
Published: (2010-10-01)

Is Effective in the Treatment of Benign Prostatic Hyperplasia?
by: Gökhan Çeker MD
Published: (2020-06-01)

Urodynamic studies in the surgical treatment of benign prostatic hyperplasia
by: Marcelo L. de Lima, et al.
Published: (2003-10-01)

Abiraterone acetate versus bicalutamide in combination with gonadotropin releasing hormone antagonist therapy for high risk metastatic hormone sensitive prostate cancer
by: Takashi Ueda, et al.
Published: (2021-05-01)

Prostatic Arterial Embolization with Small Sized Particles for the Treatment of Lower Urinary Tract Symptoms Due to Large Benign Prostatic Hyperplasia: Preliminary Results
by: Qiang Li, et al.
Published: (2015-01-01)

Multi-Matrix Approach for the Analysis of Bicalutamide Residues in Oncology Centers by HPLC–FLD
by: M. Francisca Portilha-Cunha, et al.
Published: (2021-09-01)

Prostate Artery Embolization: Treatment of Symptomatic Benign Prostatic Hyperplasia
by: Jin Ho Hwang, et al.
Published: (2019-07-01)

Treatment of Benign Prostatic Hyperplasia by Natural Drugs
by: Eszter Csikós, et al.
Published: (2021-11-01)

Therapeutic options in the treatment of benign prostatic hyperplasia
by: Jaspreet S Sandhu
Published: (2009-08-01)

Minimally invasive treatments for benign prostatic hyperplasia
by: Brian A VanderBrink, et al.
Published: (2006-01-01)

Preliminary assessment of neck circumference in benign prostatic hyperplasia in patients with metabolic syndrome
by: Yigit Akin, et al.

A case of giant prostatic hyperplasia
by: Luke Wang, et al.
Published: (2016-01-01)

Seminal vesicle abnormalities following prostatic artery embolization for the treatment of benign prostatic hyperplasia
by: Jin Long Zhang, et al.
Published: (2018-10-01)

Benign Prostatic Hyperplasia
Published: (2015-01-01)

Response to flutamide, as second-line therapy after bicalutamide, predicts efficacy of abiraterone, not that of enzalutamide
by: Yasushi Nakai, et al.
Published: (2018-05-01)

Anatomical variants in prostatic artery embolization in treatment of benign prostatic hyperplasia
by: Khaled Essam Basiouny Elsayed Basiouny, et al.
Published: (2022-05-01)

The Symptoms of Benign Prostatic Hyperplasia Patients with Stromal-Dominated Hyperplasia Nodules May Be Associated with Prostate Fibrosis
by: Cao Y, et al.
Published: (2023-04-01)

Periodontal disease and risk of benign prostate hyperplasia: a cross-sectional study
by: Lan Wu, et al.
Published: (2019-11-01)

Evaluation of neoadjuvant chemohormonal therapy before radical prostatectomy in patients with high-risk and locally advanced prostate cancer: A prospective study of goserelin and bicalutamide with or without docetaxel
by: J. Zhuang, et al.
Published: (2020-07-01)